Quality and Regulatory Sourcebook eBook March 2023
Read the article:
Evolution of Analytical Procedure Validation Concepts: Part I
Read Part II:
Evolution of Analytical Procedure Validation Concenpts: Part II
Read the eBook:
This article provides an overview of validation concept principles evolution to a life cycle risk-based approach with focus on compendial perspectives.
In recent years, regulatory agencies have placed an increased emphasis on pharmaceutical process understanding through adoption of quality-by-design (QbD) principles by launching a series of initiatives to encourage the pharmaceutical industry to adopt QbD in the manufacturing process. A key component of this transformation is the evolution of validation concepts to a life cycle risk-based approach driven by analytical quality by design (AQbD) principles. Different pharmacopoeias have been developing compendial approaches to support the implementation of analytical procedure life cycle (APLC) risk-based approach. Additionally, the International Council for Harmonisation (ICH) released in March 2022 two draft guidelines for public consultation which outline QbD principles: ICH Q14 (procedure development) (1), and the ICH Q2(R2) (procedure validation) (2). In a series of two articles, the authors will provide an overview of the validation concept principles evolution with a focus on compendial perspectives (Part I) and draw a parallel between ICH Q14 and Q2(R2) and United States Pharmacopeia (USP) General Chapter <1220> and the ISO/IEC 17025:2017 (Part II).
Read the article:
Evolution of Analytical Procedure Validation Concepts: Part I
Read Part II:
Evolution of Analytical Procedure Validation Concenpts: Part II
Read the eBook:
Read the article in BioPharm International’s Quality and Regulatory Sourcebook March 2023
Amanda Guiraldelli is scientific affairs manager at the United States Pharmacopeia.
Jane Weitzel is an independent consultant and chair of the US Pharmacopeia Expert Committee on Measurement and Data Quality.
BioPharm International
eBook: Quality and Regulatory Sourcebook 2023
March 2023
Pages: 14–21
When referring to this article, please cite it as Guiraldelli, A. and Weitzel, J. Evolution of Analytical Procedure Validation Concepts: Part I. BioPharm International Quality and Regulatory Sourcebook 2023. March 2023.
EXO Biologics and ExoXpert Reach Two Critical Milestones that Advance Exosomes
December 3rd 2024EXO Biologics and its subsidiary, ExoXpert, have received GMP certification of a European exosomes manufacturing facility and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.